fda warning glp-1 november 2025 approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly From a new Perspective by

Roughly 1 in 10 people carry a genetic variant that meaningfully blunts GLP-1 response

Acid suppression Proton pump inhibitors (PPIs): omeprazole, pantoprazole H2 receptor blockers: ranitidine, famotidine 3

Chilean AI-led food tech startup NotCo has unveiled a botanical GLP Booster powder that uses food as a natural Ozempic alternative.

Michelle Gourdine, Chief Medical Officer at CVS Caremark, explains how combining medication with health coaching and lifestyle support can help patients achieve more sustainable outcomes

Safe, reliable, cruelty-free, and suitable for all body types, this clinically tested formula delivers visible results in as little as 7 days